Isnt there a concern about the safety of generic drugs produced by compulsory licensing?
We believe that drug safety is a domestic regulatory issue, not an global trade issue worthy of trade sanctions. It is simple to use basic technology to verify the purity and content of these drugs, and there is no reason to believe that countries utilizing compulsory licensing or parallel importing would not take these measures.
